47 related articles for article (PubMed ID: 24290380)
1. Tumor burden in Hodgkin's lymphoma: much more than the best prognostic factor.
Gobbi PG
Crit Rev Oncol Hematol; 2014 Apr; 90(1):17-23. PubMed ID: 24290380
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of Hodgkin's lymphoma tumor burden in present].
Kulyova SA; Karitsky AP
Vestn Ross Akad Med Nauk; 2014; (11-12):67-71. PubMed ID: 25971129
[TBL] [Abstract][Full Text] [Related]
3. Tumor burden in Hodgkin's lymphoma can be reliably estimated from a few staging parameters.
Gobbi PG; Bergonzi M; Bassi E; Merli F; Coriani C; Stelitano C; Iannitto E; Federico M
Oncol Rep; 2012 Sep; 28(3):815-20. PubMed ID: 22752083
[TBL] [Abstract][Full Text] [Related]
4. Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapy.
Gobbi PG; Bassi E; Bergonzi M; Merli F; Coriani C; Iannitto E; Luminari S; Polimeno G; Federico M
Hematol Oncol; 2012 Dec; 30(4):194-9. PubMed ID: 22271092
[TBL] [Abstract][Full Text] [Related]
5. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
6. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma.
Qiu L; Chen Y; Wu J
Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577
[TBL] [Abstract][Full Text] [Related]
7. Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance.
Gobbi PG; Ghirardelli ML; Solcia M; Di Giulio G; Merli F; Tavecchia L; Bertè R; Davini O; Levis A; Broglia C; Maffè GC; Ilariucci F; Dore R; Ascari E
J Clin Oncol; 2001 Mar; 19(5):1388-94. PubMed ID: 11230483
[TBL] [Abstract][Full Text] [Related]
8. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
[TBL] [Abstract][Full Text] [Related]
9. Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
Rueffer U; Sieber M; Stemberg M; Gossmann A; Josting A; Koch T; Grotenhermen F; Diehl V;
Ann Hematol; 2003 Jul; 82(7):390-6. PubMed ID: 12764547
[TBL] [Abstract][Full Text] [Related]
10. Classical Hodgkin's lymphoma associated with Langerhans cell histiocytosis: multiagent chemotherapy resulted in histologic resolution of both the classical Hodgkin's lymphoma and Langerhans cell proliferation components.
Greaves WO; Bueso-Ramos C; Fayad L
J Clin Oncol; 2011 Feb; 29(4):e76-8. PubMed ID: 21041711
[No Abstract] [Full Text] [Related]
11. Management of the more common pediatric neoplasms with particular reference to Hodgkin's and non-Hodgkin's lymphoma, Wilms' tumour and neuroblastoma.
Waters KD
Paediatrician; 1980; 9(2):68-80. PubMed ID: 6248829
[TBL] [Abstract][Full Text] [Related]
12. Do we need an early unfavorable (intermediate) stage of Hodgkin's lymphoma?
Specht L; Raemaekers J
Hematol Oncol Clin North Am; 2007 Oct; 21(5):881-96. PubMed ID: 17908626
[TBL] [Abstract][Full Text] [Related]
13. [The story about Hodgkin's lymphoma].
Ostojić Kolonić S
Acta Med Croatica; 2008 Oct; 62(4):409-12. PubMed ID: 19205418
[TBL] [Abstract][Full Text] [Related]
14. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
15. [The relations between Hodgkin's and non-Hodgkin's lymphoma].
Lennert K
Arzneimittelforschung; 1987 Feb; 37(2A):255-9. PubMed ID: 3566873
[TBL] [Abstract][Full Text] [Related]
16. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
18. A primary mediastinal Hodgkin's lymphoma with asymptomatic myasthenia gravis: a rare association.
Ayadi-Kaddour A; Mlika M; Kilani T; El Mezni F
Pathologica; 2008 Jun; 100(3):170-2. PubMed ID: 18841821
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease and age.
Specht L; Nissen NI
Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
[TBL] [Abstract][Full Text] [Related]
20. Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cells.
Meignan M
Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1732-4. PubMed ID: 24906566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
